Found 5 matching trials
Study of ORIC-944 in Patients With Metastatic Prostate Cancer PHASE1 The purpose of this study is to establish the safety and preliminary antitu...
Show More Location
Rocky Mountain Cancer Center
Learn More & Join Trial
Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) PHASE1 The purpose of this study is to assess the safety and efficacy of pembroliz...
Show More Status
Active Not Recruiting
Location
Multiple Locations
Learn More & Join Trial
TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer PHASE3 The purpose of this study is to investigate the safety and efficacy of a ne...
Show More Learn More & Join Trial
Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010) PHASE3 The purpose of this study is to assess the efficacy and safety of the combi...
Show More Location
St. Joseph Heritage Healthcare ( Site 0069)
Learn More & Join Trial
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer. PHASE2 The investigators have used national VHA data to demonstrate real-world eff...
Show More Location
VA Greater Los Angeles Healthcare System
Learn More & Join Trial